Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment

Edwards Lifesciences received approval from the Food and Drug Administration for its Evoque tricuspid valve replacement system, making it the first company to bring a transcatheter treatment for tricuspid regurgitation to the U.S.